The Role of the Cytology Laboratory

Slides:



Advertisements
Similar presentations
HPV Testing and Genotyping
Advertisements

QUALITY CONTROL IN HEMATOLOGY
1 Cervical Screening Programme, England, : Graphs.
Regular Pap smears can save your life
The Cytology Laboratory Chris Faraker Clinical Cytologist East Sussex Healthcare Trust.
MANAGEMENT OF ABNORMAL PAP SMEAR
1 1 Chapter 1 Specimen Management Professor A. S. Alhomida Disclaimer The texts, tables and images contained in this course presentation (BCH 376) are.
Cervical Screening and HPV testing
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Sample Takers 2014 Cervical Sample Taker Training
How to do cervical pap smear
Detection of human telomerase gene (TERC) amplification in cervical neoplasia: A retrospective study of 79 patients Pap smear slides Renarta Crookes Sheffield.
HPV Workflow through the Cytology lab and Practical Dilemmas Kath Hunt Southmead Hospital
Sample Taker Training Cervical Cytology & Management of Abnormalities.
1 ASCO 2004 Tumor Biology & Human Genetics Pap test and a new biomarker- based technology for enhancing the visibility of abnormal cells N.S. Markovic,
Screening for Cervical Cancer
Benign and premalignant disease of the cervix
COLPOSCOPY Cervical Screening QARC Training School October 2012.
04/05/20041 Liquid Based Cytology Workshop. 04/05/20042 Programme content Session 1 : Overview of the cervical screening programme & why LBC has been.
HPV and Cervical Cancer Screening and Prevention.
Swabs Skill 304 Dr. Mohammad Marie Lecture \ 5.
Cervical screening Tim Wright Sept 07. Introduction What who when What who when Benefits (evidence) Benefits (evidence) Cost Cost Does it fit wilson’s.
Key Information about CervicalCheck for Non-Medical Staff in Primary Care.
Screening Tests for Brest & Cervical Cancer
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Overview of NHS Cervical Screening Programme Cervical Screening QARC Training School October 2012.
SoftPAP® A Novel Collection Device for Cervical Cytology.
SPAN Inaugural meeting Cervical Cytology -What Next? Jocelyn Imrie SPAN Inaugural Meeting 2 May 2006.
The Future Control of Cervical Cancer Hazel Lewis Public Health Physician Wellington Cartwright Forum, 7 August 2015.
MEDICAL TESTING Doctor requires information Patient sample collection
NHS Cervical Screening Programme, England, : Graphs.
1 Cervical Screening Programme, England, : Graphs.
The ThinPrep ® PapTest ™ PAUL SULTANA MLS Thursday, 22 October 2015.
CervicalCheck – The National Cervical Screening Programme
Top Pap smear Questions. 1-When should Pap screening begin? Age 21 y/o,3yrs after first intercourse.
What do screeners refer for checking? Allan Wilson Lead Biomedical Scientist in Cellular Pathology Advanced Practitioner in Cervical Cytology BAC 24th.
Sheffield Gynaecological Cancer CentreSheffield Teaching Hospitals PRIMARY HPV SCREENING A view from colposcopy John Tidy Consultant Gynaecological Oncologist.
Gynecologic Cytopathology
1 Cervical Screening Programme, England, : Graphs.
New Pap Technologies Pap smear screening under scrutiny since late’80s
NHS Cervical Screening Programme, England, : Graphs.
HPV testing as a Primary screening tool in England Dr Karin Denton.
Appendix 2 Comparison of screening from age 20 and age 25 Table of harms and benefits.
NHS Cervical Screening Programme Introducing HPV triage and test of cure.
Results of the HTA Adequacy Study JHF Smith Royal Hallamshire Hospital, Sheffield BAC Scientific Meeting 2013.
National Guidance By Dr Keith Faulkner, Liz Henley & Caroline Burnley Implementation of HPV Triage and Test of Cure Workshop Friday 17 th June 2011.
What is a Pap smear? A Pap smear is a test your doctor does to check for signs of cancer of the cervix. The cervix is part of your uterus (womb). During.
Prison Abnormalities Dr J H F Smith Royal Hallamshire Hospital, Sheffield East Pennine Cytology Training Centre NEYH Cervical Screening Symposium 2013.
Cytopathology Feb
Chris Marshall Cardiff 4 th year Medical Student.
Cervical Screening: Do I Really Need a Pap Test April 2010.
Understanding Test Results
Medical Diagnostic Center- L.E.M
Public Health England leads the NHS Screening Programmes
Training for Practice Nurses and Health Care Assistants on CANCER SCREENING PROGRAMMES Trainer Notes: This module can be delivered by a non clinician,
Quality issues in monitoring diagnostic and treatment performance Dr
NHS Cervical Screening Programme Introducing HPV Triage
Cytology Codes & management Colposcopy- Management of cervical lesions
Cervical Screening Programme, England, : Graphs
NHS Cervical Screening Programme, England, : Graphs
Cervical cancer & screening
NHS Cervical Screening Programme, England : Graphs
Department of Pathology
Medical Laboratory Science
Public Health England leads the NHS Screening Programmes
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
Practical of Histopathology
Presentation transcript:

The Role of the Cytology Laboratory Irene Samphier Cytology Department Pathology East Surrey Hospital

Liquid Based Cytology Randomised cells presented as a thin layer preparation on slide Cells collected with plastic broom Transported in liquid medium Smaller area to screen Better cell preservation ThinPrep and SurePath

Beware the difference Different technologies have slightly different requirements (brush head in or out) If you move areas, check technology being used Will need a short conversion course if move to a Surepath area PIN number from this training valid for all of Kent, Surrey, Sussex

Advantages of LBC Almost mono-layer of cells, therefore each cell is easy to view Cells are well preserved Facilitates 14 day turnaround Subsequent HPV typing possible

TP (Macroscopic) • The key difference in presentation is no longer seeing the smear pattern. ThinPrep takes the same material which is concentrated onto the center of the slide in a thin, uniform layer. Specimen preparation is standardized, eliminating the inconsistency associated with manual preparations.

HPV testing Not available on NHS yet, being introduced by March 2012 Testing as a low grade cytology triage test at initial diagnosis stage 2) Test of cure: negative cytology, negative HPV test, routine recall.

14 DAY Turnaround time 14 day turnaround from sample taking to the lady receiving her result Every aspect of the cervical screening has to play its part to achieve this vital sign Target is 98% 14 day TAT including time for HPV testing

PreservCyt fluid Methanol based collection fluid – health and safety considerations (toxic – keep out of reach) Wash splashes off the skin thoroughly with soap and water Eye contact: Irrigate thoroughly for at least 10 mins. If discomfort persists seek medical attention. Use by date on pot

ThinPrep® Process In the laboratory 1. Dispersion 2. Cell Collection 3. Cell Transfer

Liquid Based Cytology THINPREP™

T3000 main processor Processes up to 60,000 specimens per year Automated process Racks of 80 vials take approx 2 hours to process. Vials are bar coded T3000 reads each barcode and transfers the information to an LBC slide for that specimen

ThinPrep® 3000 Processor

Staining and Coverslipping

Papanicolaou stain Originator of the cervical smear Stain designed to be gentle on the eye and be able to see through layers of cells to the cells below Nuclear stain: Haematoxylin Cytoplasmic stains (Papanicolaou stains): EA50 and OG 6

Normal squamous cells

Coverslipping Slides are stained and then to protect the cells, a very thin glass coverslip is placed over them Stuck in place with mountant with same refractive index as glass Therefore down microscope all you see are the cells Slides are stored for 10 years for audit

Processing chain Samples and request forms checked and verified and then bar coded at original Laboratory Racks of vials sent to HUB each day for processing and staining The prepared LBC slides (and vials) next day Original Laboratory screen and report the specimens

Interpretation of reports The report will have the cytological pattern eg negative, mild dyskaryosis etc The report will be graded as the highest abnormality seen A specimen will not be called inadequate (even if very few cells present or technically inadequate) if any abnormal cells are seen.

Mild, Moderate, Severe Dyskaryosis. Cytological grading used to predict underlying histology. Mild dyskaryosis predicts CIN I Moderate dyskaryosis predicts CIN II Severe dyskaryosis predicts CIN III Borderline change – uncertain significance

The report should also have a management recommendation eg normal recall, repeat in x months, gynaecological referral etc

This laboratory operates direct referral for colposcopy for GP and community clinic samples– the result should be stamped to say this has happened if require.

Normal Cervix

Normal Cervix

Mild dyskaryosis

Mild Dyskaryosis

Mild Dyskaryosis with HPV

Mild dyskaryosis with wart virus

Moderate dyskaryosis – more cytoplasm than severe dyskaryosis

Moderate Dyskaryosis

Severe Dyskaryosis

Severe Dyskaryosis

Invasive Cancer

Abnormal Endocervicals

Dyskaryotic endocervical cells

Herpes simplex virus

Trichomonas Vaginalis

Candida

Inadequate samples due to cellularity Heavily blood stained Contamination with lubricant Insufficient cells present Cells obscured by polymorphs No endocervical cells when following up endocervical lesions

Thin prep can cope with a small amount of blood, but large quantities make the specimens inadequate Before we report a specimen as inadequate due to blood we will have reprocessed it to remove some of the blood

Inadequate samples due to paperwork/technical: Unlabelled vial Incorrectly labelled/partially incorrect Sample taken more than 6 weeks prior to receipt in lab Leaked so insufficient specimen for processing No PIN number/not recognised

Look easy?

Normal endometrial cells

Severe dyskaryosis microbiopsy

Quality assurance in the laboratory Each person reporting cervical samples (Screeners and Pathologists) participates in an interpretive EQA Quarterly statistics are performed on all the screeners work to ensure that they are competent Have to be within national detection rates - Especially important for the high grade dyskaryosis 0.8- 1.4%

KC61 Department of Health statistics –published every autumn Clinical Pathology Accreditation (CPA) QARC visits